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From the Reference Desk
from page 57
Lenburg organizes his book starting with a
“nutshell” history of animated cartoons and
then proceeds with major sections on silent
cartoon series, theatrical sound cartoons, fulllength animated features, animated television
specials, and TV cartoon series. Each entry
provides historical background information,
voice credits (except for the silent productions),
the year produced, and complete filmographies
when appropriate. Lenburg follows these
sections on the specific cartoons and cartoon
series with ones on awards and honors and a
chronology entitled milestones of animation.
He ends the book with a selected bibliography
and a general index. There are black and white
images throughout the volume but the section
of color plates in the middle is interesting and
fun to browse with images ranging from the
Chipmunks to Bevis and Butthead, Doonesbury to Davey and Goliath, and Felix the Cat
to Shrek. The Encyclopedia of Animated
Cartoons is another one of those reference
works that appeals to readers because it is
not only useful in finding elusive facts, it also
offers the enjoyment of browsing that sparks
new discoveries.

Libraries that have found the various Grey
House Publishing directories and statistical
handbooks valuable will be glad that a num-

ber of new 2008 and 2009 editions are now
available.
One of the more popular, America’s Top
Rated Cities: a Statistical Handbook (2008,
9781592373499, $225) is now in its fifteenth
edition. Divided into four volumes by region;
Southern, Western, Central and Eastern, this
set continues to provide background, rankings
and numerous statistical tables drawn from
a variety of sources on the top 100 cities in
America. Sixteen new cities have made the
most recent list and of course 16 have been
removed. Statistics and ratings related to
education, employment, income, government
expenditures, real estate, transportation, and
business are all included. Smartly compiled
with an assortment of useful information,
libraries that have purchased earlier editions
will want to continue that tradition.
A new edition of the companion set to this
work. America’s Top Rated Smaller Cities:
a Statistical Handbook 2008/2009 (978-159237-284-3, $195) is also available from
Grey House. This is the seventh edition of
this work and it consists of two volumes arranged alphabetically by state and covering 111
smaller cities ranging from Dublin, OH to Rio
Rancho, NM and from Folsom, CA to Franklin, TN. The contents are similar to the larger
four-volume set with background, ratings and
numerous statistical tables being provided for
each city. Both these sources provide useful
and fascinating information for those researching their home town or contemplating a move
to a new locale.

Another popular and useful new edition
from Grey House is the fifteenth edition
of the Complete Learning Disabilities
Directory (2008, 978-1592373680, $145).
This resource affords a comprehensive and
compact guide to a wealth of helpful information, not only for those who are learning
disabled, but also to their families and the
professionals that serve them. The nearly
5,000 entries in this work offer detailed
information about associations and government agencies, camps and summer programs,
conferences and workshops, resources for
literacy and learning skills, exchange programs, professional periodicals and texts,
testing resources, and schools and colleges.
It also contains sections that offer guidance
on computer resources as well as other media
ranging from books to pamphlets to videos
and Websites. Each entry provides the essential information to access, contact or
purchase the resources covered. As a value
added resource the National Center for
Learning Disabilities’ advocacy brief Understanding the Standards-based Individualized Education Programs is provided. This
brief explains the Standards based IEP which
is being adopted by school districts across
the country. Academic libraries supporting
special education programs as well as public
libraries where there is interest will find this
a valuable guide for students, professionals
and the general reader.

Book Reviews — Monographic Musings
Column Editor: Debbie Vaughn (College of Charleston) <vaughnd@cofc.edu>
Column Editor’s Note: In this issue, I am pleased to offer insights from two new reviewers: Katherine Head and Amber Malcolm. Both of ATG’s newest reviewers are graduate
students at the School of Library and Information Science at the University of South Carolina.
They present thoughtful reviews on books that are sure to peak your patrons’ (and perhaps
even your own!) interest. Katherine examines Melody Peterson’s Our Daily Meds. She has
learned about the pharmaceutical and medical industries through her own searching and
with the guidance of a husband in a health profession, though she freely acknowledges her
generalist status. Amber, a Disney enthusiast, hopes to one day work in the Big Apple at the
Museum of Natural History or the New York Public Library. A hearty welcome to these
budding information specialists, and happy reading, everyone! — DV

Gabler, Neal. Walt Disney: The Triumph of the American Imagination. New York:
Knoph, 2006. 9780679438229. 880 pages. $40.00.
Reviewed by Amber Malcolm (Graduate Student, School of Library and
Information Science, University of South Carolina)
Neal Gabler’s biography of Walt Disney:
The Triumph of the American Imagination
provides an intensive look into one of the
world’s most well known names. Beginning
with a comprehensive look at Walt Disney’s
family roots, Gabler takes the reader through
Disney’s life in an attempt to explain the motivations and reasoning behind the man who
became an American legend. Gabler divides
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the biography into eleven chapters — each
chapter discussing a specific period in Disney’s
life. To set the tone and pace of each chapter,
Gabler uses descriptive words and phrases for
the titles. He then stays true to the titles in such
a way that the reader is drawn completely into
an unknown side and world of Walt Disney.
Starting with the first chapter, “Escape,” Gabler pinpoints the fact that Walt was always
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looking for an “Escape” and that this was his
main motivation throughout his life. Gabler
details the Disney family legacy, which allows
the reader to see a family that was constantly
searching for something better, a way to “Escape” the realities of the world. “Escape”
dives head first into chapter two, “Go-Getter,” in which Gabler plunges the reader into
Walt’s mindset as he realizes his destiny lies
with animation. Gabler captures the sense of
urgency and motivation with which Disney
threw himself into being the best animator
possible while maintaining his underlying goal
of creating a way to “Escape” from reality.
When Walt does not get the results he hoped
from the small city, he uproots to Hollywood,
which becomes a “Wonderland,” the title of
the third chapter, for all of his dreams. What
starts out as an “Escape” and “Wonderland”
soon leads to a sour turn of events — Walt’s
company, The Disney Brothers, lost several
of their animators in a production company
dispute and are forced to start over.
Gabler transitions into “The Mouse,” the
fourth chapter, named due to Walt’s most
famous character, created not from ingenuity,
but out of necessity. Mickey Mouse starred
continued on page 59
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from page 58
in a few cartoons, namely Steamboat Willie, one
of the first sound cartoons, and was an instant hit.
The fifth chapter discusses “The Cult” that arose
from Mickey’s success and how it forever changed
animation and Walt’s life. In “Folly,” Walt once
more is blazing the trail in an effort to create an
“Escape” and on-screen “Wonderland” by making the first full length animated feature. Snow
White and the Seven Dwarfs was an incredible
success, and from there, it appeared Walt could
do no wrong — he was at the top of the mountain,
or “Parnassus,” as the seventh chapter is called.
Walt’s company produced a few films before reality caught up as World War II broke out. “Two
Wars” discusses not only the Disney company’s
involvement in the war effort and the reasoning
behind it, but also the infamous workers strike at
the company. Even with reality taking over his
studio, Walt still attempted to “Escape” by going
to South America to get inspiration for more films.
The outcome of the actual “Two Wars” left the
Disney studios somewhat “Adrift,” as the ninth
chapter focuses on Walt’s attempt to return to his
original goal of creating his own reality
and “Escape,” though he does not find
his focus until chapter ten. “City on a
Hill” shows the “Go-Getter” side of
Disney melding with his want for an
“Escape” in his attempt to create a
new kind of amusement park. Disney was able to realize his dream
for a created reality of which he was
in control, and despite his age and

decreasing health, Disney rallied his “Go-Getter” attitude to continue improving the world
around him. The final chapter, “Slouching to
Utopia,” presents Walt in his final days as he
tried to quickly accomplish as many plans as
possible in his realization of his failing health.
The biography ends with the death of Walt,
who changed America in so many ways, but
also shows that his legacy is an ongoing process
— always changing and always improving, just
as Disney lived his life.
This biography is intended for avid Disney
fans who want to know more about what drove
the man who became a household name worldwide. Gabler maintains an unbiased tone,
presenting several accounts of the stories he
includes, though one can see that Gabler holds
Disney in high regard. Gabler does not appear
to have any previous affinity or bias towards
Disney. He has authored three other books,
all dealing with Hollywood and celebrities.
Gabler has been published in several leading
newspapers and magazines, such as The New
York Times and Vogue. He also has experience
in television and currently works for PBS.
Gabler truly did his research, much of it coinciding with the reviewer’s previous knowledge
on Walt Disney. The information had
an in-depth quality about it, and overall the biography was
very thorough
and offered a
new perspective
for the reviewer.
The name “Walt
Disney” and all
that goes along
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with it is a daily part of a large majority of the
world today. While this book appears to be written
for individuals who share a passion for knowing
more about the man, Walt Disney, it could definitely be an interesting read to those with only a
mild interest. The Disney company has permeated
almost every aspect of people’s lives, and so it is
a book just about any person off the street could
relate to.
The reviewer firmly believes that this book
definitely appeals to a certain audience. The importance of the subject matter, Walt Disney’s life,
is up to the individual who might read the book.
The reviewer has a rather extensive knowledge of
Walt Disney and his empire from several other
books, but was excited to read another book with
a different perspective on the subject. This book
was one of the best on Disney and his life and
legacy and the reviewer feels it truly encompassed
the real Walt Disney and what motivated him.
The strengths of this book are too numerous to
elaborate on each, but there are one or two that
are worthy of mention. Gabler’s chapter titles
not only set the tone and pace of the chapters,
but also reflected Walt’s life in its entirety. One
could almost graph Walt’s life based on the
chapter titles and pinpoint his accomplishments
and defeats as well. Gabler also took the chapter
titles one step further and really made each chapter
its own. The “Go-Getter” and “Parnassus” are
the best examples; while reading “Go-Getter,”
the reader gets so caught up in whether or not
Disney will be able to succeed, despite knowing
the end result. Gabler’s writing style draws the
reader into Walt’s life, and the reader is able to
really experience the ups and downs alongside
continued on page 60
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Walt and his company. The book does not
just take on a lackadaisical view of Disney’s
life; instead it becomes the reader’s created
reality, with Gabler following in Walt’s
footsteps — creating a reality and an escape
for the people around him. The only weak-

ness of the book, according to the reviewer,
is the size of the book. First impressions
make the book appear to be an extremely
daunting task, with over 800 pages to read.
On second glance, one realizes that 200 of
the final pages are appendices. Overall, the
reviewer thoroughly enjoyed this biography
and recommends it for any Walt Disney fan,
new or old.

Petersen, Melody. Our Daily Meds: How the Pharmaceutical Companies
Transformed Themselves Into Slick Marketing Machines and Hooked
the Nation on Prescription Drugs. New York: Sarah Crichton
Books, 2008. 432 pages. 9780374228279. $26.00.
Reviewed by Katherine E. B. Head (Graduate Student, School of Library
and Information Science, University of South Carolina)
Over the last two decades, large companies
such as Merck, Bristol-Meyers Squibb, Phizer, and more have increasingly hired business
executives and marketers to run their companies. The effect has been increased sales, but
sometimes at the peril of the patient.
Americans are taking enough medications
to supply plenty of excess income to major
pharmaceutical producers, which largely
goes toward more marketing. According to
a study by the Kaiser Family Foundation
in May 2007, the average American picked
up more than twelve different prescriptions
from the pharmacy in 2006, up from eight in
2004. Pharmaceutical companies court physicians with extravagant vacations, dinners, and
lunches while promoting the latest prescription
drug. In 2002, Forest Labs paid for hundreds
of events including a lavish French dinner at
Daniel in Manhattan to promote their new drug
Lexapro, at which they paid physicians $500
to attend. Such dinners and conferences sometimes pose as continuing education, although
they are marketing ploys to convince doctors
to write more prescriptions for the given drug.
Pharmaceutical companies pay physicians to
promote the drug to other physicians without
disclosing their financial ties.
A danger in these promotions is that they are
sometimes based on weak or faulty evidence
of the drug’s efficacy. Until recent legislation
requiring that pharmaceutical companies release all studies for new drugs, some companies
hid results, and only released results that were
favorable. Merck, the makers of Vioxx, could
have prevented thousands of deaths if they
had not suppressed their original findings that
Vioxx increases risk of heart attacks more than
other pain medications. It took several years
of being on the market before it was pulled in
2004, but in November of that year, a scientist
from the FDA testified that Vioxx may have
caused heart attacks in as many as 139,000
Americans. Pharmaceutical companies have
also performed unethical research. Novartin’s
trial for Ritalin LA removed participants with
negative effects from the pre-trial. The industry has been known to hire ghostwriters to produce articles that depict their drug favorably,
regardless of whether the research is valid.
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The company pays physicians to “author”
such articles by “editing,” then attaching their
name and submitting it to a medical journal or
other source for publication. According to the
documents of an ex-insider of a major pharmaceutical company, the marketing firm Medical
Education Systems performed such ghostwriting services for Parke-Davis’ drug, Neurontin.
The faxed status report read “DRAFT COMPLETED. WE JUST NEED AN AUTHOR.”
This highlights the importance of peer-review
for journals. Unfortunately, even reviewers
occasionally have had ties to the industry.
In congruence with Petersen’s claims
that physicians accept financial ties to the
pharmaceutical industry, medical associations
are beginning to acknowledge the problem by
advocating against it. The National Physicians Alliance has launched the “Unbranded
Doctor Campaign” to encourage all medical
professionals to eliminate the acceptance of
gifts from pharmaceutical companies and
reduce the influence those companies have on
the field. NoFreeLunch.org is a not-for-profit
group of health care providers who “believe
that pharmaceutical promotion should not
guide practice.”
Mass amounts of money are spent on marketing while research time is spent on creating
copy-cat drugs. Zantac, for example, is a copycat of Tagamet. Vioxx was a copy-cat of Celebrex. Rather than devote R&D time toward
moving forward, pharmaceutical companies
look for ways to create the next “blockbuster”
drug. With massive marketing campaigns and
a drug that works just differently enough to
claim some type of “one-up” on its original,
the industry makes billions off copy-cat drugs.
“In 1986 Zantac passed Tagamet to become the
biggest-selling drug on earth” by marketing
essentially the same product toward heartburn
sufferers to increase the consumer numbers,
rather than focus on Tagamet’s original purpose
as a healer for stomach ulcers.
Rather than search for cures, companies
focus on chronic ailments to ensure lifelong
customers. The industry also uses marketing
to create the perception of chronic ailments
previously unlabeled as such. For example,
“overactive bladder” was coined by Phar-
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macia (now owned by Pfizer) to market their
incontinence medication, Detrol, to a larger
audience. They “sold” the phrase by paying
physicians and celebrities such as Mary Lou
Retton to speak of the serious detriment that
an overactive bladder has on a person’s life.
With a new law permitting television advertisements for prescription medications, the
company reached their target audience easily.
The same marketing strategy was applied for
PMDD (premenstrual dysphoric disorder).
“Think it’s PMS? It could be PMDD,” said
Eli Lilly’s commercials for Sarafem, a pink
and lavender repackaging of Prozac.
The industry is increasingly marketing
toward a younger audience to gain life-time
customers. National Depression Screening
Day is a campaign organized by Screening
for Mental Health, Inc. (funded by Eli Lilly,
Pfizer, Wyeth, Forest Laboratories, and
GlaxoSmithKline — all makers of anti-depressant drugs). The day involves “screening”
college students with brief surveys looking
for symptoms of stress, anxiety, and sadness
— all symptoms one would expect in the
average college student. At Central College
in Pella, Iowa, the results of the screening
indicated “almost half” of the 190 students
who took the test scored “diagnosis likely,
further evaluation needed.”
The information in Petersen’s nonfiction
book is relevant to every American, as we
are exposed to pharmaceutical marketing
when we watch television or read a magazine.
The free samples we get from our doctors
would not be there without pharmaceutical
companies’ marketing strategies. We should
all be informed consumers. While Petersen
does not downplay the real need for pharmaceutical medications, she challenges the
deceptive mass marketing strategies that
have become commonplace in the industry.
The book is well worth the price. It might
save you hundreds of dollars on unnecessary
prescriptions, and an informed consumer can
ask doctors better questions and recognize
marketing schemes.
Melody Petersen is a journalist who
covered pharmaceutical companies for the
New York Times from 1999 until 2003. On
the same subject is Hooked: Ethics, Medicine,
and Pharma by Howard Brody, MD, PhD.
On his blog, Brody credits Petersen with her
series of articles in the Times for inspiring his
work. Petersen’s book is straightforward and
understandable for someone without a background in the medical field. It is loaded in the
back with a Notes section, full of citations and
support for her claims. This reviewer only
has two complaints: 1) Topics are sometimes
dropped and revisited later, making the book
occasionally seem out of chronological and/or
sequential order. Nevertheless, it was not a
difficult book to follow overall; and 2) In the
first chapter, Petersen briefly diverts from
pharmaceutical companies and prescription drugs to share statistics about money
wasted on unnecessary tests and procedures.
The paragraph is not long enough for her to
explore the argument and back up her comments.
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